Moderna vaccine is first mRNA jab to get emergency-use nod in India

Path cleared for importing foreign regulator-approved vaccines without bridging clinical studies; Moderna jab has 94.1% efficacy

India on Tuesday approved a fourth Covid-19 vaccine, and its first mRNA vaccine, Moderna’s mRNA-1273, thereby clearing the path for importing foreign regulator-approved Covid vaccines to India without bridging clinical studies. Moderna vaccine which has 94.1 percent efficacy will be available here through its Indian partner Cipla.

Cipla did not respond till the time of going to press.

US vaccine makers Pfizer and Moderna had sought indemnity against serious adverse events following vaccination, an immunity they enjoy in other countries where they supply. This matter is under consideration, said V K Paul, member,health NITI Aayog.

Paul confirmed that Moderna’s application for emergency use